Literature DB >> 17266202

In silico prediction of cytochrome P450 2D6 and 3A4 inhibition using Gaussian kernel weighted k-nearest neighbor and extended connectivity fingerprints, including structural fragment analysis of inhibitors versus noninhibitors.

Berith F Jensen1, Christian Vind, Søren B Padkjaer, Per B Brockhoff, Hanne H F Refsgaard.   

Abstract

Inhibition of cytochrome P450 (CYP) enzymes is unwanted because of the risk of severe side effects due to drug-drug interactions. We present two in silico Gaussian kernel weighted k-nearest neighbor models based on extended connectivity fingerprints that classify CYP2D6 and CYP3A4 inhibition. Data used for modeling consisted of diverse sets of 1153 and 1382 drug candidates tested for CYP2D6 and CYP3A4 inhibition in human liver microsomes. For CYP2D6, 82% of the classified test set compounds were predicted to the correct class. For CYP3A4, 88% of the classified compounds were correctly classified. CYP2D6 and CYP3A4 inhibition were additionally classified for an external test set on 14 drugs, and multidimensional scaling plots showed that the drugs in the external test set were in the periphery of the training sets. Furthermore, fragment analyses were performed and structural fragments frequent in CYP2D6 and CYP3A4 inhibitors and noninhibitors are presented.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17266202     DOI: 10.1021/jm060333s

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  20 in total

1.  Evaluation of descriptors and classification schemes to predict cytochrome substrates in terms of chemical information.

Authors:  John H Block; Douglas R Henry
Journal:  J Comput Aided Mol Des       Date:  2008-01-23       Impact factor: 3.686

Review 2.  Current Approaches for Investigating and Predicting Cytochrome P450 3A4-Ligand Interactions.

Authors:  Irina F Sevrioukova; Thomas L Poulos
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

3.  In silico prediction of ROCK II inhibitors by different classification approaches.

Authors:  Chuipu Cai; Qihui Wu; Yunxia Luo; Huili Ma; Jiangang Shen; Yongbin Zhang; Lei Yang; Yunbo Chen; Zehuai Wen; Qi Wang
Journal:  Mol Divers       Date:  2017-08-02       Impact factor: 2.943

4.  Cheminformatics models based on machine learning approaches for design of USP1/UAF1 abrogators as anticancer agents.

Authors:  Divya Wahi; Salma Jamal; Sukriti Goyal; Aditi Singh; Ritu Jain; Preeti Rana; Abhinav Grover
Journal:  Syst Synth Biol       Date:  2015-01-30

5.  In silico prediction of hERG potassium channel blockage by chemical category approaches.

Authors:  Chen Zhang; Yuan Zhou; Shikai Gu; Zengrui Wu; Wenjie Wu; Changming Liu; Kaidong Wang; Guixia Liu; Weihua Li; Philip W Lee; Yun Tang
Journal:  Toxicol Res (Camb)       Date:  2016-01-14       Impact factor: 3.524

6.  Trainable structure-activity relationship model for virtual screening of CYP3A4 inhibition.

Authors:  Remigijus Didziapetris; Justas Dapkunas; Andrius Sazonovas; Pranas Japertas
Journal:  J Comput Aided Mol Des       Date:  2010-09-01       Impact factor: 3.686

Review 7.  Considerations and recent advances in QSAR models for cytochrome P450-mediated drug metabolism prediction.

Authors:  Haiyan Li; Jin Sun; Xiaowen Fan; Xiaofan Sui; Lan Zhang; Yongjun Wang; Zhonggui He
Journal:  J Comput Aided Mol Des       Date:  2008-06-24       Impact factor: 3.686

8.  Benchmarking ligand-based virtual High-Throughput Screening with the PubChem database.

Authors:  Mariusz Butkiewicz; Edward W Lowe; Ralf Mueller; Jeffrey L Mendenhall; Pedro L Teixeira; C David Weaver; Jens Meiler
Journal:  Molecules       Date:  2013-01-08       Impact factor: 4.411

9.  Designing of inhibitors against drug tolerant Mycobacterium tuberculosis (H37Rv).

Authors:  Deepak Singla; Rupinder Tewari; Ashwani Kumar; Gajendra Ps Raghava
Journal:  Chem Cent J       Date:  2013-03-08       Impact factor: 4.215

10.  Redefining Cheminformatics with Intuitive Collaborative Mobile Apps.

Authors:  Alex M Clark; Sean Ekins; Antony J Williams
Journal:  Mol Inform       Date:  2012-07-04       Impact factor: 3.353

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.